Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery
Clinical trial NCT05695391 · TERMINATED
Trial details
- NCT number
- NCT05695391
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2025-05-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.